Table of Content

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in diagnostics dealmaking
2.1. Introduction
2.2. Diagnostics partnering over the years
2.3. Most active diagnostics dealmakers
2.4. Diagnostics partnering by deal type
2.5. Diagnostics partnering by therapy area
2.6. Deal terms for diagnostics partnering
2.6.1 Diagnostics partnering headline values
2.6.2 Diagnostics deal upfront payments
2.6.3 Diagnostics deal milestone payments
2.6.4 Diagnostics royalty rates

Chapter 3 – Leading diagnostics deals
3.1. Introduction
3.2. Top diagnostics deals by value

Chapter 4 – Most active diagnostics dealmakers
4.1. Introduction
4.2. Most active diagnostics dealmakers
4.3. Most active diagnostics partnering company profiles

Chapter 5 – Diagnostics contracts dealmaking directory
5.1. Introduction
5.2. Diagnostics contracts dealmaking directory

Chapter 6 – Diagnostics dealmaking by technology type

Appendices

Appendix 1 – Diagnostics deals by company A-Z

Appendix 2 – Diagnostics deals by stage of development

Appendix 3 – Diagnostics deals by deal type

Appendix 4 – Diagnostics deals by therapy area

Appendix 5 – Deal type definitions

Appendix 6 – Further reading on dealmaking

About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from Current Partnering

Table of figures

Figure 1: Diagnostics partnering since 2016
Figure 2: Active diagnostics dealmaking activity since 2016
Figure 3: Diagnostics partnering by deal type since 2016
Figure 4: Diagnostics partnering by disease type since 2016
Figure 5: Diagnostics deals with a headline value
Figure 6: Diagnostics deals with an upfront value
Figure 7: Diagnostics deals with a milestone value
Figure 8: Diagnostics deals with a royalty rate value
Figure 9: Top diagnostics deals by value since 2016
Figure 10: Most active diagnostics dealmakers since 2016